Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Effect and mechanism of tigecycline on proliferation of liver tumor cells in mouse model]. | Zhonghua Yi Xue Za Zhi | 2025 | 40619969 | PubTator, text mining | PubMed |
| THEM6 modulates carboplatin sensitivity by regulating ferroptosis through FDFT1 in triple-negative breast cancer. | Breast Cancer Res | 2025 | 40619388 | PubTator, text mining | PubMed |
| miRNAome-metabolome wide association study reveals effects of miRNA regulation in male diabetic erectile dysfunction. | Free Radic Biol Med | 2025 | 40618911 | PubTator, text mining | PubMed |
| Involvement of ferroptosis in lipopolysaccharide-induced intestinal inflammation in broilers. | Poult Sci | 2025 | 40618566 | PubTator, text mining | PubMed |
| MicroRNAs at the crossroads of exercise and ferroptosis: a regulatory bridge. | Clin Exp Med | 2025 | 40618320 | PubTator, text mining | PubMed |
| FBXO10 inhibits ferroptosis and promotes the progression of esophageal squamous cell carcinoma by post-translational mediation of ACSL4 degradation. | J Mol Histol | 2025 | 40616744 | PubTator, text mining | PubMed |
| YLKTT, a potent biopeptide that ameliorates oxygen-glucose deprivation-induced neuronal cell ferroptosis by ACSL4/GPX4 and SLC7A11/GPX4 axis. | J Pharm Pharmacol | 2025 | 40613764 | PubTator, text mining | PubMed |
| Atorvastatin Calcium Enhances Ferroptosis in Breast Cancer Cells Through Mechanisms Involving DECR1. | Front Biosci (Landmark Ed) | 2025 | 40613293 | PubTator, text mining | PubMed |
| Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer. | Int J Biol Sci | 2025 | 40612672 | PubTator, text mining | PubMed |
| Exploring the role of ferroptosis in pemphigus: identification of diagnostic markers and regulatory mechanisms. | Front Med (Lausanne) | 2025 | 40612574 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma-derived protein encapsulated iron oxide/black phosphorus nanosheets for targeted photothermal-chemotherapy. | Biomed Mater | 2025 | 40609604 | PubTator, text mining | PubMed |
| Ferroptosis in Gastrointestinal Diseases: A New Frontier in Pathogenesis and Therapy. | J Clin Med | 2025 | 40565780 | PubTator, text mining | PubMed |
| CircRNA_1156 Attenuates Neodymium Nitrate-Induced Hepatocyte Ferroptosis by Inhibiting the ACSL4/PKCβII Signaling Pathway. | Antioxidants (Basel) | 2025 | 40563332 | PubTator, text mining | PubMed |
| Effects and mechanisms of aflatoxin B1 on oocytes and embryo development. | Ecotoxicol Environ Saf | 2025 | 40561604 | PubTator, text mining | PubMed |
| Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer. | Oncotarget | 2025 | 40560062 | PubTator, text mining | PubMed |
| Targeting Ferroptosis in Tumors: Novel Marine-Derived Compounds as Regulators of Lipid Peroxidation and GPX4 Signaling. | Mar Drugs | 2025 | 40559667 | PubTator, text mining | PubMed |
| Ginsenoside (20)S-APPT induces ferroptosis in hepatocellular carcinoma and cholangiocarcinoma by targeting FSP1. | Acta Pharmacol Sin | 2025 | 40550962 | PubTator, text mining | PubMed |
| The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets. | Apoptosis | 2025 | 40544405 | PubTator, text mining | PubMed |
| Fe2O3 nanoparticles induce ferroptosis by binding to the N-terminus of ACSL4 and suppressing its ubiquitin-mediated degradation. | Free Radic Biol Med | 2025 | 40543851 | PubTator, text mining | PubMed |
| Associations between serum levels of ferroptosis-related molecules and outcomes in stable COPD: an exploratory prospective observational study. | Intern Emerg Med | 2025 | 40542968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=39